Focal adhesion kinase as potential target for cancer therapy (Review).
暂无分享,去创建一个
Yasuhiro Shirakawa | Kazufumi Sakurama | Yoshio Naomoto | Y. Naomoto | Y. Shirakawa | K. Noma | Takayuki Motoki | J. Matsuoka | M. Takaoka | Munenori Takaoka | Y. Tomono | Takuya Fukazawa | Junji Matsuoka | T. Fukazawa | T. Yamatsuji | Huifang Hao | Xiaohong Bao | Nobuyuki Watanabe | Kazuhiro Noma | Takayuki Motoki | Yasuko Tomono | Tomoki Yamatsuji | Z G Wang | Huifang Hao | Xiao-hong Bao | Kazufumi Sakurama | Nobuyuki Watanabe | Z. G. Wang
[1] R. Anderegg,et al. Activation of a Novel Calcium-dependent Protein-tyrosine Kinase , 1996, The Journal of Biological Chemistry.
[2] R. Klemke,et al. Extracellular-Regulated Kinase Activation and Cas/Crk Coupling Regulate Cell Migration and Suppress Apoptosis during Invasion of the Extracellular Matrix , 2000, The Journal of cell biology.
[3] Jie J. Zheng,et al. Structural Insight into the Mechanisms of Targeting and Signaling of Focal Adhesion Kinas , 2002, Molecular and Cellular Biology.
[4] W. Cance,et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[5] J. Parsons,et al. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK , 1993, Molecular and cellular biology.
[6] D. Kerr,et al. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Guan,et al. Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration* , 1999, The Journal of Biological Chemistry.
[8] D. Schlaepfer,et al. Control of motile and invasive cell phenotypes by focal adhesion kinase. , 2004, Biochimica et biophysica acta.
[9] J. Guan,et al. Regulation of Focal Adhesion Kinase by Its Amino-Terminal Domain through an Autoinhibitory Interaction , 2003, Molecular and Cellular Biology.
[10] Michael D Schaller,et al. The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.
[11] C. Livasy,et al. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis , 2004, Breast Cancer Research and Treatment.
[12] J. Parsons,et al. Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.
[13] Bob van de Water,et al. Focal adhesion kinase: a potential target in cancer therapy. , 2007, Biochemical pharmacology.
[14] J. Parsons,et al. Identification of integrin-stimulated sites of serine phosphorylation in FRNK, the separately expressed C-terminal domain of focal adhesion kinase: a potential role for protein kinase A. , 1997, The Biochemical journal.
[15] C. Damsky,et al. Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis , 1998, The Journal of cell biology.
[16] W. Cance,et al. Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.
[17] S. C. Liu,et al. The FERM domain: A unique module involved in the linkage of cytoplasmic proteins to the membrane , 1998 .
[18] D. Schlaepfer,et al. Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.
[19] G. Rosen,et al. Cleavage of Focal Adhesion Kinase by Caspases during Apoptosis* , 1997, The Journal of Biological Chemistry.
[20] T. Hunter,et al. Signal transduction from the extracellular matrix--a role for the focal adhesion protein-tyrosine kinase FAK. , 1996, Cell structure and function.
[21] Nils Cordes,et al. Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.
[22] Gareth E. Jones,et al. Focal adhesion kinase controls actin assembly via a FERM-mediated interaction with the Arp2/3 complex , 2007, Nature Cell Biology.
[23] S. Aizawa,et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.
[24] C. Damsky,et al. Matrix survival signaling: from fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase. , 2000 .
[25] M. Schwartz,et al. Integrins regulate the apoptotic response to DNA damage through modulation of p53 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Frame,et al. Targeted proteolysis of the focal adhesion kinase pp125 FAK during c-MYC-induced apoptosis is suppressed by integrin signalling. , 1996, Oncogene.
[27] S. Hanks,et al. Induced Focal Adhesion Kinase (FAK) Expression in FAK-Null Cells Enhances Cell Spreading and Migration Requiring Both Auto- and Activation Loop Phosphorylation Sites and Inhibits Adhesion-Dependent Tyrosine Phosphorylation of Pyk2 , 1999, Molecular and Cellular Biology.
[28] S. Hanks,et al. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Parsons,et al. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK , 1996, Nature.
[30] Hai Lu,et al. Squamous cell carcinoma cell aggregates escape suspension-induced, p53-mediated anoikis: fibronectin and integrin alphav mediate survival signals through focal adhesion kinase. , 2004, The Journal of biological chemistry.
[31] J. Guan,et al. Transcriptional activation of cyclin D1 promoter by FAK contributes to cell cycle progression. , 2001, Molecular biology of the cell.
[32] V. Golubovskaya,et al. TAE226‐Induced apoptosis in breast cancer cells with overexpressed Src or EGFR , 2008, Molecular carcinogenesis.
[33] J. Parsons,et al. Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation , 1997, Molecular and cellular biology.
[34] K. Vuori,et al. The adaptor protein Crk connects multiple cellular stimuli to the JNK signaling pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] V. Golubovskaya,et al. p53 regulates FAK expression in human tumor cells , 2008, Molecular carcinogenesis.
[36] Matthew D. Wessel,et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.
[37] W. Yung,et al. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo , 2007, Molecular Cancer Therapeutics.
[38] M. Schaller. Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.
[39] Martin E M Noble,et al. The structural basis of localization and signaling by the focal adhesion targeting domain. , 2002, Structure.
[40] J. Parsons,et al. pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] R. Assoian,et al. Growth control by intracellular tension and extracellular stiffness. , 2008, Trends in cell biology.
[42] M. Eck,et al. Crystal Structure of the FERM Domain of Focal Adhesion Kinase* , 2006, Journal of Biological Chemistry.
[43] R. Liddington,et al. The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin , 2002, Nature Structural Biology.
[44] J. Parsons,et al. Regulated Expression of Focal Adhesion Kinase-Related Nonkinase, the Autonomously Expressed C-Terminal Domain of Focal Adhesion Kinase , 1999, Molecular and Cellular Biology.
[45] M. Brown,et al. Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding , 1996, The Journal of cell biology.
[46] Liz Y. Han,et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. , 2007, Cancer research.
[47] Christopher Autry,et al. Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.
[48] Osamu Ohmori,et al. A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth , 2007, Molecular carcinogenesis.
[49] G. Draetta. Mammalian G1 cyclins. , 1994, Current opinion in cell biology.
[50] C. Beaudry,et al. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation. , 2003, Molecular cancer research : MCR.
[51] T. Hunter,et al. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases , 1996, Molecular and cellular biology.
[52] J. Taylor,et al. A Role for Focal Adhesion Kinase in Phenylephrine-induced Hypertrophy of Rat Ventricular Cardiomyocytes* , 2000, The Journal of Biological Chemistry.
[53] J. Parsons,et al. Interaction of Focal Adhesion Kinase with Cytoskeletal Protein Talin (*) , 1995, The Journal of Biological Chemistry.
[54] E. Ruoslahti,et al. Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.
[55] J. Parsons,et al. Induction of Apoptosis after Expression of PYK2, a Tyrosine Kinase Structurally Related to Focal Adhesion Kinase , 1997, The Journal of cell biology.
[56] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[57] C. Turner,et al. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly , 1992, The Journal of cell biology.
[58] D. Brenner,et al. The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.
[59] E. Peles,et al. Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.
[60] J. Guan,et al. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. , 1996, Journal of cell science.
[61] C. Livasy,et al. Focal Adhesion Kinase Overexpression in Endometrial Neoplasia , 2004, Applied immunohistochemistry & molecular morphology : AIMM.
[62] W. Cance,et al. The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[63] F. Fiedorek,et al. Mapping of the focal adhesion kinase (Fadk) gene to mouse Chromosome 15 and human Chromosome 8 , 1995, Mammalian Genome.
[64] C. Morimoto,et al. Direct association of pp125FAK with paxillin, the focal adhesion- targeting mechanism of pp125FAK , 1995, The Journal of experimental medicine.
[65] J. Parsons,et al. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions , 1993, The Journal of cell biology.
[66] Zhiqiang Li,et al. Antisense oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cells , 2006, Journal of Neuro-Oncology.
[67] Shiro Watanabe,et al. FAK Is the Upstream Signal Protein of the Phosphatidylinositol 3-Kinase-Akt Survival Pathway in Hydrogen Peroxide-induced Apoptosis of a Human Glioblastoma Cell Line* , 1999, The Journal of Biological Chemistry.
[68] C. Gladson,et al. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation , 2006, Journal of cellular biochemistry.
[69] S. Hanks,et al. Identification of p130Cas as a Mediator of Focal Adhesion Kinase–promoted Cell Migration , 1998, The Journal of cell biology.
[70] C. Livasy,et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[71] V. Golubovskaya,et al. Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53* , 2005, Journal of Biological Chemistry.
[72] V. Golubovskaya,et al. Focal adhesion kinase and cancer. , 2009, Histology and histopathology.
[73] D. Schlaepfer,et al. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. , 2001, Cancer research.
[74] Q. Ding,et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[75] S. Grant,et al. Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.
[76] Jie J. Zheng,et al. Structural features of the focal adhesion kinase–paxillin complex give insight into the dynamics of focal adhesion assembly , 2005, Protein science : a publication of the Protein Society.
[77] K. Vuori,et al. CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration , 1998, The Journal of cell biology.
[78] Xinming Cai,et al. Structural Basis for the Autoinhibition of Focal Adhesion Kinase , 2007, Cell.
[79] Robert A. H. White,et al. Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) , 1995, The Journal of Biological Chemistry.
[80] Guillermina Lozano,et al. MDM2, an introduction. , 2003, Molecular cancer research : MCR.
[81] Christopher A Lipinski,et al. The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. , 2005, Neoplasia.
[82] Terukatsu Sasaki,et al. Cloning and Characterization of Cell Adhesion Kinase β, a Novel Protein-tyrosine Kinase of the Focal Adhesion Kinase Subfamily (*) , 1995, The Journal of Biological Chemistry.
[83] Susan J Fisher,et al. Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.
[84] D. Schlaepfer,et al. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.
[85] D. Yamamoto,et al. FAK overexpression upregulates cyclin D3 and enhances cell proliferation via the PKC and PI3-kinase-Akt pathways. , 2003, Cellular signalling.
[86] S. Kanner,et al. A transmembrane-anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK. , 1994, The Journal of biological chemistry.
[87] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[88] G. Semenza,et al. Molecular Events Implicated in Brain Tumor Angiogenesis and Invasion , 2000, Pediatric Neurosurgery.
[89] M. Schaller,et al. FAK regulates biological processes important for the pathogenesis of cancer , 2003, Cancer and Metastasis Reviews.
[90] V. Golubovskaya,et al. Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.
[91] J. Parsons,et al. Regulation of focal adhesion targeting and inhibitory functions of the FAK related protein FRNK using a novel estrogen receptor "switch". , 2002, Cell motility and the cytoskeleton.
[92] D. Beer,et al. Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo , 2008, Clinical Cancer Research.
[93] K. Nave,et al. FAK Deficiency in Cells Contributing to the Basal Lamina Results in Cortical Abnormalities Resembling Congenital Muscular Dystrophies , 2003, Neuron.
[94] S. Hanks,et al. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.
[95] J. Parsons,et al. Selective Expression of an Endogenous Inhibitor of FAK Regulates Proliferation and Migration of Vascular Smooth Muscle Cells , 2001, Molecular and Cellular Biology.
[96] C. Damsky,et al. FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.
[97] K. Vousden. Switching from life to death: the Miz-ing link between Myc and p53. , 2002, Cancer cell.
[98] R. Flavell,et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis , 2005, The Journal of cell biology.
[99] I. Zachary,et al. Focal adhesion kinase. , 1997, The international journal of biochemistry & cell biology.
[100] S. Hanks,et al. Anti-apoptotic Role of Focal Adhesion Kinase (FAK) , 2000, The Journal of Biological Chemistry.
[101] R L Juliano,et al. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. , 1992, The Journal of biological chemistry.
[102] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.